Cx32 was found to decrease tumor growth, invasion, and metastasis of renal cell carcinoma cell lines via multiple modulators, including Src, tight junction proteins, and vascular endothelial growth factor (VEGF), independent of GJIC function (199). This evidence concerns the gene SRC and neoplasm.